Patents by Inventor Mika Okuda

Mika Okuda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9775884
    Abstract: A fibrinogen preparation is provided which has an improved solubility, may be prepared within a short time and may be used rapidly in clinical set-up. A solid fibrinogen preparation comprising as a main ingredient fibrinogen and further containing the following components: albumin; a nonionic surfactant; a basic amino acid or a salt thereof; and at least two amino acids or a salt thereof selected from an acidic amino acid or a salt thereof and a neutral amino acid or a salt thereof. The solid fibrinogen composition of the present invention may be held on a medical material to form a supporting material holding fibrinogen. Besides, the supporting material holding fibrinogen may be combined with a component comprising as a main ingredient thrombin to provide a fibrin adhesive.
    Type: Grant
    Filed: March 21, 2008
    Date of Patent: October 3, 2017
    Assignee: The Chemo-Sero-Therapeutic Research Institute
    Inventors: Shinichi Miyagawa, Tatsuya Araki, Tsutomu Hamuro, Mika Okuda, Hiroshi Kaetsu
  • Publication number: 20100119563
    Abstract: A fibrinogen preparation is provided which has an improved solubility, may be prepared within a short time and may be used rapidly in clinical set-up. A solid fibrinogen preparation comprising as a main ingredient fibrinogen and further containing the following components: albumin; a nonionic surfactant; a basic amino acid or a salt thereof; and at least two amino acids or a salt thereof selected from an acidic amino acid or a salt thereof and a neutral amino acid or a salt thereof. The solid fibrinogen composition of the present invention may be held on a medical material to form a supporting material holding fibrinogen. Besides, the supporting material holding fibrinogen may be combined with a component comprising as a main ingredient thrombin to provide a fibrin adhesive.
    Type: Application
    Filed: March 21, 2008
    Publication date: May 13, 2010
    Applicant: Juridical Fdn. The Chemo-Sero-Therap Res. Ins.
    Inventors: Shinichi Miyagawa, Tatsuya Araki, Tsutomu Hamuro, Mika Okuda, Hiroshi Kaetsu